Follow The Filings

KRMN Karman

Karman earnings company data as of 12:01 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.15 — —
Rev — — —

Insider trades

Open-market buys and sales by KRMN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KRMN insider trades
  • $1M bought by 3 insiders
  • None no sales outside a trading plan
  • $41.2M sold by 5 insiders under 10b5-1 plans
  1. David Stinnett Director
    Buy
    $1M 27,000 shares at $37.32 +0.8% to stake
    Traded Sep 16 Filed Sep 18
  2. Mary D Petryszyn Director
    Buy
    $19K 500 shares at $37.44 +21% to stake
    Traded Sep 16 Filed Sep 18
  3. Stephen Twitty Director
    Buy
    $10K 275 shares at $36.79 +12% to stake
    Traded Sep 16 Filed Sep 18
  4. Anthony Koblinski CEO
    Planned sale
    $5.2M 75,000 shares at $69.31 3.1% of stake
    Traded Dec 12, 2025 Filed Dec 15, 2025
  5. Anthony Koblinski CEO
    Planned sale
    $5M 75,000 shares at $66.51 3% of stake
    Traded Dec 5, 2025 Filed Dec 8, 2025
  6. Anthony Koblinski CEO
    Planned sale
    $5.1M 75,000 shares at $67.40 3% of stake
    Traded Nov 28, 2025 Filed Dec 1, 2025
  7. Anthony Koblinski CEO
    Planned sale
    $4.4M 75,000 shares at $58.48 2.9% of stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
  8. Michael Willis CFO
    Planned sale
    $6.7M 115,000 shares at $58.63 12% of stake
    Traded Nov 17, 2025 Filed Nov 18, 2025
  9. Jonathan Beaudoin COO
    Planned sale
    $4.7M 74,000 shares at $63.69 10% of stake
    Traded Nov 13, 2025 Filed Nov 14, 2025
  10. Stephanie Sawhill Chief Growth Officer
    Planned sale
    $4M 62,000 shares at $63.93 11% of stake
    Traded Nov 13, 2025 Filed Nov 14, 2025
  11. Brian Raduenz Director
    Planned sale
    $6.1M 90,000 shares at $68.00 26% of stake
    Traded Nov 12, 2025 Filed Nov 13, 2025

Also filed in the last 12 months, not counted as buying or selling: 13 stock grants.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13G —
8-K 7.01,9.01
8-K 1.01,2.03,7.01,8.01,9.01
8-K 5.02,7.01,9.01
10-Q
SCHEDULE 13G/A —
8-K 1.01,2.03,9.01
8-K 2.02,9.01
8-K 4.01,9.01
8-K 1.01,7.01,8.01,9.01
424B7
424B7
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
8-K 5.07
DEF 14A
10-K
SCHEDULE 13G/A —
8-K 2.02,9.01
8-K 1.01,2.03,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.